PSDV


MLV Reiterates Buy On pSivida As All Eyes On Iluvien US Launch

In a research report issued today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 price target, following …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts